Skip to main content
10 May 2024
Last updated:
Friday 10 May 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Seismic shift ahead for drug pricing
Read more
Drugs for orphan diseases are no longer rare
Read more
Why patient-reported outcomes matter
Read more
Is an EU approval better than a hospital exemption?
Read more
Q1 2017 stock market report: Biotechs climb to the top of the tree
Read more
MedNous Briefing - The European Medicine Agency's PRIME Scheme
Read more
Immunotherapies start to transform cancer care
Read more
Targeting the tumour microenvironment
Read more
The Trump impact on healthcare M&A
Read more
WHO identifies bacteria posing the greatest threat
Read more
Pagination
First page
« First
Previous page
‹‹
…
Page
35
Page
36
Page
37
Page
38
Current page
39
Page
40
Page
41
Page
42
Page
43
…
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form